McGuire Investment Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-35,484
| Closed | -$348K | – | 119 |
|
|
2023
Q4 | $348K | Buy |
35,484
+8,664
| +32% | +$85K | 0.06% | 92 |
|
|
2023
Q3 | $224K | Hold |
26,820
| – | – | 0.04% | 105 |
|
|
2023
Q2 | $357K | Buy |
26,820
+6,669
| +33% | +$88.7K | 0.07% | 88 |
|
|
2023
Q1 | $233K | Buy |
20,151
+2,000
| +11% | +$23.2K | 0.05% | 100 |
|
|
2022
Q4 | $148K | Sell |
18,151
-2,000
| -10% | -$16.4K | 0.03% | 109 |
|
|
2022
Q3 | $117K | Buy |
20,151
+2,000
| +11% | +$11.6K | 0.03% | 109 |
|
|
2022
Q2 | $80K | Hold |
18,151
| – | – | 0.02% | 116 |
|
|
2022
Q1 | $165K | Buy |
+18,151
| New | +$165K | 0.03% | 122 |
|